These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 11245074

  • 1. Serological diagnosis of nasopharyngeal carcinoma by enzyme linked immunosorbent assay: optimization, standardization and diagnostic criteria.
    Ng MH, Chen HL, Luo RX, Chan KH, Woo PC, Sham JS, Huang J, Seto WH, Smith P, Griffin BE.
    Chin Med J (Engl); 1998 Jun; 111(6):531-6. PubMed ID: 11245074
    [Abstract] [Full Text] [Related]

  • 2. Complementary serum test of antibodies to Epstein-Barr virus nuclear antigen-1 and early antigen: a possible alternative for primary screening of nasopharyngeal carcinoma.
    Chang KP, Hsu CL, Chang YL, Tsang NM, Chen CK, Lee TJ, Tsao KC, Huang CG, Chang YS, Yu JS, Hao SP.
    Oral Oncol; 2008 Aug; 44(8):784-92. PubMed ID: 18206420
    [Abstract] [Full Text] [Related]

  • 3. Single-assay combination of Epstein-Barr Virus (EBV) EBNA1- and viral capsid antigen-p18-derived synthetic peptides for measuring anti-EBV immunoglobulin G (IgG) and IgA antibody levels in sera from nasopharyngeal carcinoma patients: options for field screening.
    Fachiroh J, Paramita DK, Hariwiyanto B, Harijadi A, Dahlia HL, Indrasari SR, Kusumo H, Zeng YS, Schouten T, Mubarika S, Middeldorp JM.
    J Clin Microbiol; 2006 Apr; 44(4):1459-67. PubMed ID: 16597877
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Evaluation of combined determinations of Epstein-Barr virus antibodies for nasopharyngeal carcinoma assessed with receiver operating characteristic curve based on logistic regression].
    Cai YL, Zheng YM, Cheng JR, Li J, Mo YK, Zhong QY.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Oct; 23(5):384-7. PubMed ID: 20387494
    [Abstract] [Full Text] [Related]

  • 7. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.
    Shao JY, Li YH, Gao HY, Wu QL, Cui NJ, Zhang L, Cheng G, Hu LF, Ernberg I, Zeng YX.
    Cancer; 2004 Mar 15; 100(6):1162-70. PubMed ID: 15022282
    [Abstract] [Full Text] [Related]

  • 8. Epstein Barr virus (EBV) antibodies in the diagnosis of NPC--comparison between IFA and two commercial ELISA kits.
    Chan SH, Soo MY, Gan YY, Fones-Tan A, Sim PS, Kaur A, Chew CT.
    Singapore Med J; 1998 Jun 15; 39(6):263-5. PubMed ID: 9803815
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Analyses of the prognostic significance of the Epstein-Barr virus transactivator ZEBRA protein and diagnostic value of its two synthetic peptides in nasopharyngeal carcinoma.
    Dardari R, Menezes J, Drouet E, Joab I, Benider A, Bakkali H, Kanouni L, Jouhadi H, Benjaafar N, El Gueddari B, Hassar M, Khyatti M.
    J Clin Virol; 2008 Feb 15; 41(2):96-103. PubMed ID: 18024156
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Serum responses to the combination of Epstein-Barr virus antigens from both latent and acute phases in nasopharyngeal carcinoma: complementary test of EBNA-1 with EA-D.
    Chow KC, Ma J, Lin LS, Chi KH, Yen SH, Liu SM, Liu WT, Chen WK, Chang TH, Chen KY.
    Cancer Epidemiol Biomarkers Prev; 1997 May 15; 6(5):363-8. PubMed ID: 9149897
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Evaluation of Epstein-Barr virus antigen-based immunoassays for serological diagnosis of nasopharyngeal carcinoma.
    Tang JW, Rohwäder E, Chu IM, Tsang RK, Steinhagen K, Yeung AC, To KF, Chan PK.
    J Clin Virol; 2007 Dec 15; 40(4):284-8. PubMed ID: 17977062
    [Abstract] [Full Text] [Related]

  • 16. Comparison of three different serological techniques for primary diagnosis and monitoring of nasopharyngeal carcinoma in two age groups from Tunisia.
    Karray H, Ayadi W, Fki L, Hammami A, Daoud J, Drira MM, Frikha M, Jlidi R, Middeldorp JM.
    J Med Virol; 2005 Apr 15; 75(4):593-602. PubMed ID: 15714486
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Expression, purification and diagnostic application of EBV TK kinase].
    Huang B, Li B, Zhou W, Pi G, Tang W, Gu S.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Jun 15; 16(2):184-6. PubMed ID: 12196837
    [Abstract] [Full Text] [Related]

  • 20. Enhancing the efficiency of Epstein-Barr viral serologic test in the diagnosis of nasopharyngeal carcinoma.
    Zhang C, Zong Y, Huang B, Sun Y, Ye Y, Feng K, Li J, Zhang F.
    Zhonghua Zhong Liu Za Zhi; 2002 Jul 15; 24(4):356-9. PubMed ID: 12408763
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.